The oncosuppressor p53 is either lost or mutated in about half of all human cancers40, and the consequent p53 LOF has a critical impact on DNA damage repair, cell cycle checkpoint control, and apoptosis, which in turn result in the enhanced propensity of tumor cells to evolve toward invasive and metastatic transformation. Here, TP53 is linked to neoplasm.